Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.

@article{Lazzarotto2017ClinicalOO,
  title={Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.},
  author={Davide Lazzarotto and Anna Candoni and Carla Fil{\'i} and Fabio Forghieri and Livio Pagano and Alessandro Busca and Giuseppina Spinosa and Maria Elena Zannier and Erica Simeone and Miriam Isola and Erika Borlenghi and Lorella Melillo and Federico Mosna and Federica Lessi and Renato Fanin},
  journal={Leukemia research},
  year={2017},
  volume={53},
  pages={74-81}
}
INTRODUCTION Myeloid Sarcoma (MS) is a rare hematologic myeloid neoplasm that can involve any site of the body. It can occur as an exclusively extramedullary form or it can be associated with an acute myeloid leukemia (AML), a chronic myeloproliferative neoplasm (MPN) or a myelodysplastic syndrome (MDS) at onset or at relapse. The rarity of MS does not enable prospective clinical trials and therefore a specific multicenter register can be useful for the clinical and biological studies of this… CONTINUE READING